Compare Pfizer Inc (PFE) vs QUALCOMM, Inc. (QCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs QUALCOMM, Inc. — how do they compare? Pfizer Inc trades at $24.91 (market cap $142.14B), while QUALCOMM, Inc. trades at $176.95 (market cap $182.87B). The key difference: QUALCOMM, Inc. is the larger of the two by market cap, and Pfizer Inc pays the higher dividend (6.9%). Which is the better fit depends on your goals.
| PFE | QCOM | |
|---|---|---|
Market Cap | $142.14B | $182.87B |
Volume | 29,869,932 | — |
Sector | Health | Technology |
52-Week High | $28.56 | $251.10 |
52-Week Low | $23.29 | $124.07 |
Enterprise Value | $192.80B | $188.34B |
Dividend Yield | 6.9% | 2.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $24.83, up 0.32% today, with a neutral technical signal and bearish moving averages. The company reported revenue of $62.58B in 2025, with a net income margin of 11.83%, and has beaten EPS estimates for the last three quarters. Recent news highlights pipeline developments in oncology and obesity, with a consensus analyst price target of $28.25.
PFE offers a stable dividend and trades below analyst targets, but faces headwinds from patent expirations and volatile cash flows. The stock presents value with a P/E of 19.04, though growth depends on successful drug launches and navigating post-COVID revenue normalization.
Qualcomm (QCOM) trades at $175.55, up 3.07% today, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with a 22.31% net income margin and 29.27% ROE, though margins face pressure. Analyst consensus is a $228.22 price target with 42.65% buy ratings. Recent news highlights AI and data center growth initiatives amid smartphone market challenges.
The outlook balances AI diversification potential against near-term margin and competitive risks. Investment opportunity lies in data center revenue growth and market share gains, but risks include Nvidia's PC chip entry and handset demand softness. Wall Street remains cautiously optimistic with a hold-heavy rating distribution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About QUALCOMM, Inc.
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.
Read more on QCOM →
